PharmaCielo Ltd. PCLOF PCLO made it first shipment of dried cannabis flowers with THC dominance to a customer in the Czech Republic, on the EU market. The client is an established cannabinoids-focused pharmaceutical distributor and clinical research organization in the country. The customer is currently importing cannabinoids from the Netherlands and Canada.
Bill PetronPharmaCielo CEO, stated, “PharmaCielo’s global business development team continues to make significant strides in expanding the Company’s commercial pipeline and setting the stage for accelerated growth beginning in 2023. The EU is the biggest opportunity for global cannabinoid exporters, and PharmaCielo is well positioned to gain market share over current vendors with a combination of proprietary Colombian strains, high-quality products, and low production costs. Our team has made significant strides in multiple markets recently , including Germany, Israel, Brazil, Mexico, Poland and now the Czech Republic. We expect the combination of these recent developments and continued sales efforts will make the next eighteen months a pivotal time for the Company.”
About PharmaCielo
PharmaCielo Ltd. is a global company headquartered in Canada focused on the ethical and sustainable cultivation, processing and supply of all natural, pharmaceutical grade medicinal dried cannabis flower and cannabis products to major distribution channels. The main subsidiary of PharmaCielo is PharmaCielo Colombia Holdings SASheadquartered at its cultivation and processing center in Rionegro, Colombia.
Photo of CRYSTALWEED cannabis on Unsplash
Similar news
Cannabis M&A Update: Aurora, TerrAscend, SNDL, Curaleaf and…a Costly Preferred Stock Raid?
PharmaCielo Completes First Shipment of Cannabinoid Products to Mexican Joint Venture Partners
